Thymotrinan is a short regulatory peptide enriched with charged residues that facilitate dynamic secondary-structure transitions. The motif supports analysis of interaction hotspots, conformational plasticity, and hydrogen-bonding networks. Researchers apply it to map protein-binding determinants and structural rearrangements. Its simplicity aids biophysical characterization.
CAT No: R2235
CAS No:85465-82-3
Synonyms/Alias:Thymotrinan;Arg-Lys-Asp;85465-82-3;Thymotrinan [INN];Timotrinan;arginyl-lysyl-aspartic acid;L-Arginyl-L-lysyl-L-aspartic acid;(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]butanedioic acid;THYMOPOIETIN II (32-34);29OE04A6C9;Rgh 0205;Thymotrinanum;RGH-0205;Timotrinan [INN-Spanish];Thymotrinanum [INN-Latin];UNII-29OE04A6C9;RGH 0205; TP 3;N-(N(sup 2)-L-Arginyl-L-lysyl)-L-aspartic acid;SCHEMBL62515;L-Aspartic acid, N-(N(sup 2)-L-arginyl-L-lysyl)-;CHEMBL2105488;SCHEMBL15532089;DTXSID60234687;CHEBI:159125;AKOS040754202;HY-106765;CS-0026503;NS00123466;Q27254434;(S)-2-((S)-6-amino-2-((S)-2-amino-5-guanidinopentanamido)hexanamido)succinic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More